Search

Your search keyword '"Alavi, Afsaneh"' showing total 966 results
Start Over Author "Alavi, Afsaneh"
966 results on '"Alavi, Afsaneh"'

4. Wound bed preparation 2024: Delphi consensus on foot ulcer management in resource-limited settings

Author

Smart, Hiske, Sibbald, R Gary, Goodman, Laurie, Elizabeth, A Ayello, Jaimangal, Reneeka, Gregory, John H, Akita, Sadanori, Alavi, Afsaneh, Armstrong, David G, Arputhanathan, Helen, Bruwer, Febe, Caul, Jeremy, Chan, Beverley, Cronje, Frans, Dofitas, Belen, Hamed, Jassin, Harley, Catherine, Heil, Jolene, Hill, Mary, Jahnke, Devon, Kalina, Dale, Kodange, Chaitanya, Kotru, Bharat, Kozody, Laura Lee, Landis, Stephan, LeBlanc, Kimberly, MacDonald, Mary, Mark, Tobi, Martin, Carlos, Mayer, Dieter, Murphy, Christine, Nair, Harikrishna, Orellana, Cesar, Ostrow, Brian, Queen, Douglas, Rainville, Patrick, Rajhathy, Erin, Schultz, Gregory, Somayaji, Ranjani, Stacey, Michael C, Tariq, Gulnaz, Weir, Gregory, Whiteside, Catharine, Yifter, Helen, and Zacharias, Ramesh

Published
2024

5. IRAK4 degrader in hidradenitis suppurativa and atopic dermatitis: a phase 1 trial

Author

Ackerman, Lindsay, Acloque, Gerard, Bacchelli, Sandro, Schwartz, Howard, Feinstein, Brian J., La Stella, Phillip, Alavi, Afsaneh, Gollerkeri, Ashwin, Davis, Jeffrey, Campbell, Veronica, McDonald, Alice, Agarwal, Sagar, Karnik, Rahul, Shi, Kelvin, Mishkin, Aimee, Culbertson, Jennifer, Klaus, Christine, Enerson, Bradley, Massa, Virginia, Kuhn, Eric, Sharma, Kirti, Keaney, Erin, Barnes, Randy, Chen, Dapeng, Zheng, Xiaozhang, Rong, Haojing, Sabesan, Vijay, Ho, Chris, Mainolfi, Nello, Slavin, Anthony, and Gollob, Jared A.

Published
2023
Full Text
View/download PDF

7. Wound bed preparation

Author

Sibbald, R Gary, Elliott, James A, Persaud-Jaimangal, Reneeka, Goodman, Laurie, Armstrong, David G, Harley, Catherine, Coelho, Sunita, Xi, Nancy, Evans, Robyn, Mayer, Dieter O, Zhao, Xiu, Heil, Jolene, Kotru, Bharat, Delmore, Barbara, LeBlanc, Kimberly, Ayello, Elizabeth A, Smart, Hiske, Tariq, Gulnaz, Alavi, Afsaneh, and Somayaji, Ranjani

Published
2022

9. Eligibility Criteria for Active Ulcerative Pyoderma Gangrenosum in Clinical Trials: A Delphi Consensus on Behalf of the UPGRADE (Understanding Pyoderma Gangrenosum: Review and Assessment of Disease Effects) Group

Author

Kamal, Kanika, Xia, Eric, Li, Sara J., Alavi, Afsaneh, Cogen, Anna L., Firooz, Alireza, Marzano, Angelo V., Kaffenberger, Benjamin H., Sibbald, Cathryn, Fernandez, Anthony P., Callen, Jeffrey P., Dissemond, Joachim, Gontijo, João Renato V., Shams, Kave, Gerbens, Louise A., French, Lars E., Gould, Lisa J., Bissonnette, Robert, Shaigany, Sheila, Tolkachjov, Stanislav, Yamamoto, Toshiyuki, Wei-Ting Huang, William, Ortega-Loayza, Alex G., and Mostaghimi, Arash

Published
2024
Full Text
View/download PDF

11. Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations

Author

Garg, Amit, Malviya, Neeta, Strunk, Andrew, Wright, Shari, Alavi, Afsaneh, Alhusayen, Raed, Alikhan, Ali, Daveluy, Steven D, Delorme, Isabelle, Goldfarb, Noah, Gulliver, Wayne, Hamzavi, Iltefat, Jaleel, Tarannum, Kimball, Alexa B, Kirby, Joslyn S, Kirchhof, Mark G, Lester, Janice, Lev-Tov, Hadar, Lowes, Michelle A, Micheletti, Robert, Orenstein, Lauren A, Piguet, Vincent, Sayed, Christopher, Tan, Jerry, and Naik, Haley B

Subjects
Clinical Research, Health Services, Obesity, Prevention, Digestive Diseases, Aetiology, 2.1 Biological and endogenous factors, Cardiovascular, Good Health and Well Being, Canada, Comorbidity, Female, Hidradenitis Suppurativa, Humans, Metabolic Syndrome, Pyoderma Gangrenosum, acne, cardiovascular disease, comorbidity, Crohn's disease, depression, dermatologist, diabetes mellitus, dissecting cellulitis of the scalp, down syndrome, dyslipidemia, generalized anxiety disorder, guidelines, herpes zoster, hidradenitis suppurativa, hypertension, inflammatory bowel disease, lymphoma, metabolic syndrome, North America, obesity, pilonidal disease, polycystic ovary syndrome, pyoderma gangrenosum, screening, sexual dysfunction, smoking, spondyloarthritis, substance use, suicide, systemic, ulcerative colitis, Clinical Sciences, Dermatology & Venereal Diseases
Abstract

BackgroundHidradenitis suppurativa (HS) is associated with comorbidities that contribute to poor health, impaired life quality, and mortality risk.ObjectiveTo provide evidence-based screening recommendations for comorbidities linked to HS.MethodsSystematic reviews were performed to summarize evidence on the prevalence and incidence of 30 comorbidities in patients with HS relative to the general population. The screening recommendation for each comorbidity was informed by the consistency and quality of existing studies, disease prevalence, and magnitude of association, as well as benefits, harms, and feasibility of screening. The level of evidence and strength of corresponding screening recommendation were graded by using the Strength of Recommendation Taxonomy (SORT) criteria.ResultsScreening is recommended for the following comorbidities: acne, dissecting cellulitis of the scalp, pilonidal disease, pyoderma gangrenosum, depression, generalized anxiety disorder, suicide, smoking, substance use disorder, polycystic ovary syndrome, obesity, dyslipidemia, diabetes mellitus, metabolic syndrome, hypertension, cardiovascular disease, inflammatory bowel disease, spondyloarthritis, and sexual dysfunction. It is also recommended to screen patients with Down syndrome for HS. The decision to screen for specific comorbidities may vary with patient risk factors. The role of the dermatologist in screening varies according to comorbidity.LimitationsScreening recommendations represent one component of a comprehensive care strategy.ConclusionsDermatologists should support screening efforts to identify comorbid conditions in HS.

Published
2022

15. The “Understanding Pyoderma Gangrenosum, Review and Assessment of Disease Effects (UPGRADE)” Project: a protocol for the development of the core outcome domain set for trials in pyoderma gangrenosum

Author

Rick, Jonathan, Gould, Lisa J., Marzano, Angelo Valerio, Garg, Amit, Chen, Diana, Oakes, Debbie L., Dissemond, Joachim, Herfarth, Hans, Friedman, Marcia A., Alavi, Afsaneh, Yamamoto, Toshiyuki, Gerbens, Louise A. A., Thomas, Kim S., and Ortega-Loayza, Alex G.

Published
2023
Full Text
View/download PDF

19. Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials

Author

Kimball, Alexa B, Jemec, Gregor B E, Alavi, Afsaneh, Reguiai, Ziad, Gottlieb, Alice B, Bechara, Falk G, Paul, Carle, Giamarellos Bourboulis, Evangelos J, Villani, Axel P, Schwinn, Andreas, Ruëff, Franziska, Pillay Ramaya, Larisha, Reich, Adam, Lobo, Ines, Sinclair, Rodney, Passeron, Thierry, Martorell, Antonio, Mendes-Bastos, Pedro, Kokolakis, Georgios, Becherel, Pierre-Andre, Wozniak, Magdalena B, Martinez, Angela Llobet, Wei, Xiaoling, Uhlmann, Lorenz, Passera, Anna, Keefe, Deborah, Martin, Ruvie, Field, Clarice, Chen, Li, Vandemeulebroecke, Marc, Ravichandran, Shoba, and Muscianisi, Elisa

Published
2023
Full Text
View/download PDF

22. Discrepancies in hidradenitis suppurativa lesion characterization by providers and patients

Author

Greenlund, Lindsey, primary, Herzog, Claire, additional, Wendland, Zachary, additional, Rypka, Katelyn, additional, Frew, John W., additional, Kirby, Joslyn S., additional, Alavi, Afsaneh, additional, Khalid, Bisma, additional, Lowes, Michelle A., additional, Garg, Amit, additional, Marzano, Angelo V., additional, Zouboulis, Christos C., additional, Tzellos, Thrasyvoulos, additional, Jaleel, Tarannum, additional, and Goldfarb, Noah, additional

Published
2024
Full Text
View/download PDF

28. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations Part II: Topical, intralesional, and systemic medical management

Author

Alikhan, Ali, Sayed, Christopher, Alavi, Afsaneh, Alhusayen, Raed, Brassard, Alain, Burkhart, Craig, Crowell, Karen, Eisen, Daniel B, Gottlieb, Alice B, Hamzavi, Iltefat, Hazen, Paul G, Jaleel, Tara, Kimball, Alexa B, Kirby, Joslyn, Lowes, Michelle A, Micheletti, Robert, Miller, Angela, Naik, Haley B, Orgill, Dennis, and Poulin, Yves

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Management of diseases and conditions, 7.3 Management and decision making, Administration, Oral, Administration, Topical, Androgen Antagonists, Anti-Bacterial Agents, Canada, Evidence-Based Medicine, Female, Hidradenitis Suppurativa, Humans, Immunosuppressive Agents, Injections, Intralesional, Male, North America, Practice Guidelines as Topic, Prognosis, Publications, Risk Assessment, Treatment Outcome, United States, acne inversa, adalimumab, biomarkers, carbon dioxide laser, clindamycin, comorbidities, ertapenem, finasteride, guidelines, hidradenitis suppurativa, infliximab, laser, lifestyle modification, microbiome, Nd:YAG, oral contraceptive pills, rifampin, spironolactone, Dermatology & Venereal Diseases, Clinical sciences
Abstract

Hidradenitis suppurativa is a severe and debilitating dermatologic disease. Clinical management is challenging and consists of both medical and surgical approaches, which must often be combined for best outcomes. Therapeutic approaches have evolved rapidly in the last decade and include the use of topical therapies, systemic antibiotics, hormonal therapies, and a wide range of immunomodulating medications. An evidence-based guideline is presented to support health care practitioners as they select optimal medical management strategies and is reviewed in this second part of the management guidelines. A therapeutic algorithm informed by the evidence available at the time of the review is provided.

Published
2019

29. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations Part I: Diagnosis, evaluation, and the use of complementary and procedural management

Author

Alikhan, Ali, Sayed, Christopher, Alavi, Afsaneh, Alhusayen, Raed, Brassard, Alain, Burkhart, Craig, Crowell, Karen, Eisen, Daniel B, Gottlieb, Alice B, Hamzavi, Iltefat, Hazen, Paul G, Jaleel, Tara, Kimball, Alexa B, Kirby, Joslyn, Lowes, Michelle A, Micheletti, Robert, Miller, Angela, Naik, Haley B, Orgill, Dennis, and Poulin, Yves

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Anti-Bacterial Agents, Biological Products, Canada, Complementary Therapies, Dermatologic Surgical Procedures, Drug Therapy, Combination, Evidence-Based Medicine, Female, Hidradenitis Suppurativa, Humans, Immunosuppressive Agents, Male, North America, Practice Guidelines as Topic, Publishing, Risk Assessment, Severity of Illness Index, United States, acne inversa, adalimumab, biomarkers, carbon dioxide laser, clindamycin, comorbidities, ertapenem, finasteride, guidelines, hidradenitis suppurativa, infliximab, laser, lifestyle modification, microbiome, Nd:YAG, oral contraceptive pills, rifampin, spironolactone, Dermatology & Venereal Diseases, Clinical sciences
Abstract

Hidradenitis suppurativa is a chronic inflammatory disorder affecting hair follicles, with profoundly negative impact on patient quality of life. Evidence informing ideal evaluation and management of patients with hidradenitis suppurativa is still sparse in many areas, but it has grown substantially in the last decade. Part I of this evidence-based guideline is presented to support health care practitioners as they select optimal management strategies, including diagnostic testing, comorbidity screening, and both complementary and procedural treatment options. Recommendations and evidence grading based on the evidence available at the time of the review are provided.

Published
2019

30. Are Bacteria Infectious Pathogens in Hidradenitis Suppurativa? Debate at the Symposium for Hidradenitis Suppurativa Advances Meeting, November 2017

Author

Naik, Haley B, Nassif, Aude, Ramesh, Mayur S, Schultz, Gregory, Piguet, Vincent, Alavi, Afsaneh, and Lowes, Michelle A

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Infectious Diseases, 2.1 Biological and endogenous factors, Aetiology, Infection, Good Health and Well Being, Bacteria, Congresses as Topic, Hidradenitis Suppurativa, Humans, Microbiota, Retrospective Studies, Oncology and Carcinogenesis, Dermatology & Venereal Diseases, Clinical sciences
Abstract

In November 2017, a formal debate on the role of bacteria in the pathogenesis of hidradenitis suppurativa (HS) was held at the 2nd Symposium on Hidradenitis Suppurativa Advances (SHSA) in Detroit, Michigan. In this report, we present both sides of the argument as debated at the SHSA meeting and then discuss the potential role of bacteria as classic infectious pathogens versus an alternative pathogenic role as activators of dysregulated commensal bacterial-host interactions. Although there was consensus that bacteria play a role in pathogenesis and thus are pathogenic, there was a compelling discussion about whether bacteria in HS incite an infectious disease as we classically understand it or whether bacteria might play a different role in HS pathogenesis.

Published
2019

31. Proceeding report of the Second Symposium on Hidradenitis Suppurativa Advances (SHSA) 2017

Author

Shavit, Eran, Alavi, Afsaneh, Bechara, Falk G, Bennett, Richard G, Bourcier, Marc, Cibotti, Ricardo, Daveluy, Steven, Frew, John W, Garg, Amit, Hamzavi, Iltefat, Hoffman, Lauren K, Hsaio, Jenny, Kirby, Joslyn Sciacca, Lev‐Tov, Hadar, Martinez, Erin, Micheletti, Robert, Naik, Haley B, Nassif, Aude, Nicholson, Cynthia, Parks‐Miller, Angie, Patel, Zarine, Piguet, Vincent, Ramesh, Mayur, Resnik, Barry, Sayed, Christopher, Schultz, Gregory, Siddiqui, Aamir, Tan, Jerry, Wortsman, Ximena, and Lowes, Michelle A

Subjects
Anti-Infective Agents, Anti-Inflammatory Agents, Biomedical Research, Comorbidity, Dermatologic Surgical Procedures, Hidradenitis Suppurativa, Humans, Incidence, Quality of Life, Tumor Necrosis Factor-alpha, Ultrasonography, hidradenitis suppurativa, symposium, Clinical Sciences, Dermatology & Venereal Diseases
Abstract

The 2nd Annual Symposium on Hidradenitis Suppurativa Advances (SHSA) took place on 03-05 November 2017 in Detroit, Michigan, USA. This symposium was a joint meeting of the Hidradenitis Suppurativa Foundation (HSF Inc.) founded in the USA, and the Canadian Hidradenitis Suppurativa Foundation (CHSF). This was the second annual meeting of the SHSA with experts from different disciplines arriving from North America, Europe and Australia, in a joint aim to discuss most recent innovations, practical challenges and potential solutions to issues related in the management and care of Hidradenitis Suppurativa patients. The last session involved clinicians, patients and their families in an effort to educate them more about the disease.

Published
2019

32. Vascular Studies for Nonvascular Surgeons

Author

Rajabi-Estarabadi, Ali, Forouzandeh, Mahtab, Kayssi, Ahmed, Kirsner, Robert S., Alavi, Afsaneh, Berth-Jones, John, Series Editor, Goh, Chee Leok, Series Editor, Maibach, Howard I., Series Editor, and Alavi, Afsaneh, editor

Published
2020
Full Text
View/download PDF

33. Wound Healing in Pyoderma Gangrenosum

Author

Ali, Asma Asif Amir, Marzano, Angelo Valerio, Alavi, Afsaneh, Berth-Jones, John, Series Editor, Goh, Chee Leok, Series Editor, Maibach, Howard I., Series Editor, and Alavi, Afsaneh, editor

Published
2020
Full Text
View/download PDF

37. Inpatient Management of Hidradenitis Suppurativa: A Delphi Consensus Study.

Author

Needham, McKenzie, Pichardo, Rita, Alavi, Afsaneh, Chang, Aileen Y., Daveluy, Steven, DeNiro, Katherine L., Dewan, Anna, Eshaq, Milad, Fox, Lindy, Hsiao, Jennifer Lin, Kaffenberger, Benjamin Harris, Kirby, Joslyn S., Kroshinsky, Daniela, Ortega-Loayza, Alex G., Manusco, Jennifer Brescoll, Micheletti, Robert G., Mostaghimi, Arash, Nelson, Caroline A., Pasieka, Helena B., and Porter, Martina L.

Subjects
HIDRADENITIS suppurativa, DELPHI method, INPATIENT care, PATIENT care, DERMATOLOGISTS, HOSPITAL care
Abstract

Inpatient hospitalization of individuals with hidradenitis suppurativa (HS) has increased. Inpatient services may not be familiar enough with this disease to understand how to manage severe HS and/or HS flares. It would be beneficial to the inpatient medical community to establish consensus recommendations on holistic inpatient care of patients with HS. A survey study was developed and distributed by Wake Forest University School of Medicine (Winston-Salem, North Carolina). A total of 26 dermatologists participated in the Delphi process, and the process was conducted in 2 rounds. Participants voted on proposal statements using a 9-point scale (1=very inappropriate; 9=very appropriate). Statements were developed using current published guidelines for management of HS and supportive care guidelines for other severe inpatient dermatologic diseases. A total of 50 statements were reviewed and voted on between the 2 rounds. Consensus was determined using the RAND/UCLA Appropriateness Method. Twenty-six dermatologists completed the first-round survey, and 24 completed the second-round survey. The 40 consensus recommendations generated through these surveys can serve as a resource for providers caring for inpatients with HS. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

39. Contributors

Author

Alavi, Afsaneh, primary, Aleshin, Maria, additional, Bechara, Falk G., additional, Bennett, Richard G., additional, Birnbaum, Ron, additional, Brownstone, Nicholas, additional, Buechler, Connor R., additional, Shree' Byrd, Angel, additional, Charrow, Alexandra P., additional, Cole, Emily F., additional, Collier, Erin K., additional, Daveluy, Steven D., additional, Fernandez, Jennifer M., additional, Frew, John W., additional, Garg, Amit, additional, George, Ralph, additional, Goldberg, Stephanie R., additional, Goldfarb, Noah, additional, Guilbault, Sandra, additional, Hamzavi, Iltefat H., additional, Hazen, Paul G., additional, Henderson, Marsha, additional, Hendricks, Aleksi J., additional, Hsiao, Jennifer L., additional, Jaleel, Tarannum, additional, Johnson, Lydia J., additional, Join-Lambert, Olivier, additional, Kerns, Michelle L., additional, Kimball, Alexa B., additional, Kirby, Joslyn S., additional, Kohli, Indermeet, additional, Lenczowski, Joi, additional, Lev-Tov, Hadar, additional, Liao, Wilson, additional, Lowes, Michelle A., additional, Lyons, Alexis B., additional, Malviya, Neeta, additional, Micheletti, Robert G., additional, Morss-Walton, Peyton C., additional, Myers, Bridget, additional, Naik, Haley B., additional, Narla, Shanthi, additional, Nassif, Aude, additional, Nguyen, Tien Viet, additional, Nikolakis, Georgios, additional, O'Brien, Elizabeth, additional, Orenstein, Lauren A.V., additional, Parks-Miller, Angie, additional, Patel, Zarine S., additional, Porter, Martina L., additional, Price, Kyla N., additional, Ramesh, Mayur, additional, Resnik, Barry I., additional, Santillan, Monica Rosales, additional, Sachdeva, Muskaan, additional, Sanchez, Daniela P., additional, Savage, Kevin T., additional, Sayed, Chris, additional, Shah, Monica, additional, Shaver, Rob Leland, additional, Shi, Vivian Y., additional, Smogorzewski, Jan M., additional, Succaria, Farah, additional, Svoboda, Ryan M., additional, Thompson, Alyssa M., additional, Vaiopoulos, Aristeidis G., additional, Veerabagu, Surya A., additional, Walsh, Joseph R., additional, Weigelt, Maximillian A., additional, Wortsman, Ximena, additional, and Zouboulis, Christos C., additional

Published
2022
Full Text
View/download PDF

41. The Global Hidradenitis Suppurativa Atlas (GHiSA) Methodology: Combining Global Proportions in a Pooled Analysis

Author

Bouazzi, Dorra, primary, Andersen, Rune Kjærsgaard, additional, Vinding, Gabrielle R., additional, Medianfar, Cecilia E., additional, Nielsen, Sabrina Mai, additional, Saunte, Ditte M. L., additional, Chandran, Nisha S., additional, van der Zee, Hessel H., additional, Zouboulis, Christos C., additional, Benhadou, Farida, additional, Villumsen, Bente, additional, Alavi, Afsaneh, additional, Ibekwe, Perpetua U., additional, Hamzavi, Iltefat H., additional, Ingram, John R., additional, Naik, Haley B., additional, Garg, Amit, additional, Boer, Jurr, additional, Christensen, Robin, additional, and Jemec, Gregor B.E., additional

Published
2024
Full Text
View/download PDF

42. Wound Bed Preparation 2024: Delphi Consensus on Foot Ulcer Management in Resource-Limited Settings

Author

Smart, Hiske, primary, Sibbald, R. Gary, additional, Goodman, Laurie, additional, Ayello, Elizabeth A., additional, Jaimangal, Reneeka, additional, Gregory, John H., additional, Akita, Sadanori, additional, Alavi, Afsaneh, additional, Armstrong, David G., additional, Arputhanathan, Helen, additional, Bruwer, Febe, additional, Caul, Jeremy, additional, Chan, Beverley, additional, Cronje, Frans, additional, Dofitas, Belen, additional, Hamed, Jassin, additional, Harley, Catherine, additional, Heil, Jolene, additional, Hill, Mary, additional, Jahnke, Devon, additional, Kalina, Dale, additional, Kodange, Chaitanya, additional, Kotru, Bharat, additional, Kozody, Laura Lee, additional, Landis, Stephan, additional, LeBlanc, Kimberly, additional, MacDonald, Mary, additional, Mark, Tobi, additional, Martin, Carlos, additional, Mayer, Dieter, additional, Murphy, Christine, additional, Nair, Harikrishna, additional, Orellana, Cesar, additional, Ostrow, Brian, additional, Queen, Douglas, additional, Rainville, Patrick, additional, Rajhathy, Erin, additional, Schultz, Gregory, additional, Somayaji, Ranjani, additional, Stacey, Michael C., additional, Tariq, Gulnaz, additional, Weir, Gregory, additional, Whiteside, Catharine, additional, Yifter, Helen, additional, and Zacharias, Ramesh, additional

Published
2024
Full Text
View/download PDF

46. Eligibility Criteria for Active Ulcerative Pyoderma Gangrenosum in Clinical Trials: A Delphi Consensus on Behalf of the UPGRADE (Understanding Pyoderma Gangrenosum: Review and Assessment of Disease Effects) Group

Author

Kamal, Kanika, primary, Xia, Eric, additional, Li, Sara J., additional, Alavi, Afsaneh, additional, Cogen, Anna L., additional, Firooz, Alireza, additional, Marzano, Angelo V., additional, Kaffenberger, Benjamin H., additional, Sibbald, Cathryn, additional, Fernandez, Anthony P., additional, Callen, Jeffrey P., additional, Dissemond, Joachim, additional, Gontijo, João Renato V., additional, Shams, Kave, additional, Gerbens, Louise A., additional, French, Lars E., additional, Gould, Lisa J., additional, Bissonnette, Robert, additional, Shaigany, Sheila, additional, Tolkachjov, Stanislav, additional, Yamamoto, Toshiyuki, additional, Wei-Ting Huang, William, additional, Ortega-Loayza, Alex G., additional, and Mostaghimi, Arash, additional

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results